Neoadjuvant vidutolimod and nivolumab in high-risk resectable melanoma: A prospective phase II trial

Authors: Davar, Diwakar, Morrison, Robert M., Dzutsev, Amiran K., Karunamurthy, Arivarasan, Chauvin, Joe-Marc, Amatore, Florent, Deutsch, Julie S., Das Neves, Rodrigo X., Rodrigues, Richard R., McCulloch, John A., Wang, Hong, Hartman, Douglas J., Badger, Jonathan H., Fernandes, Miriam R., Bai, Yulong, Sun, Jie, Cole, Alicia M., Aggarwal, Poonam, Fang, Jennifer R., Deitrick, Christopher, Bao, Riyue, Duvvuri, Umamaheswar, Sridharan, Shaum S., Kim, Seungwon W., A. Choudry, Haroon, Holtzman, Matthew P., Pingpank, James F., O'Toole, James Patrick, DeBlasio, Richelle, Jin, Yang, Ding, Quanquan, Gao, Wentao, Groetsch, Christopher, Pagliano, Ornella, Rose, Amy, Urban, Corey, Singh, Jagjit, Divarkar, Prajan, Mauro, David, Bobilev, Dmitri, Wooldridge, James, Krieg, Arthur M., Fury, Matthew G., Whiteaker, Jeffrey R., Zhao, Lei, Paulovich, Amanda G., Najjar, Yana G., Luke, Jason J., Kirkwood, John M., Taube, Janis M., Park, Hyun Jung, Trinchieri, Giorgio, Zarour, Hassane M.

Source: In Cancer Cell 11 November 2024 42(11):1898-1918

Human NK cells prime inflammatory DC precursors to induce Tc17 differentiation

Authors: Clavijo-Salomon, Maria A., Salcedo, Rosalba, Roy, Soumen, das Neves, Rodrigo X., Dzutsev, Amiran, Sales-Campos, Helioswilton, Borbely, Karen Steponavicius-Cruz, Silla, Lucia, Orange, Jordan S., Mace, Emily M., Barbuto, José A.M., Trinchieri, Giorgio ^{*, *, *}

Source: In Blood Advances 25 August 2020 4(16):3990-4006

This result is not displayed to guests.
Login for full access.